UBS AM
AXGN icon

UBS AM’s Axogen AXGN Stock Holding History

UBS AM’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.67M Buy
79,524
+18,754
+31% +$756K ﹤0.01% 1759
2026
Q1 		$2.01M Buy
60,770
+520
+0.9% +$16.9K ﹤0.01% 2043
2025
Q4 		$1.97M Buy
60,250
+5,305
+10% +$130K ﹤0.01% 1886
2025
Q3 		$980K Sell
54,945
-57,436
-51% -$833K ﹤0.01% 2019
2025
Q2 		$1.22M Buy
112,381
+70,871
+171% +$928K ﹤0.01% 2339
2025
Q1 		$768K Buy
+41,510
New +$749K ﹤0.01% 2405
2023
Q4 		– Sell
-10,538
Closed -$52.7K – 2548
2023
Q3 		$52.7K Buy
+10,538
New +$73K ﹤0.01% 2577
2023
Q1 		– Sell
-21,390
Closed -$213K – 2680
2022
Q4 		$213K Buy
+21,390
New +$238K ﹤0.01% 2428
2022
Q2 		– Sell
-40,741
Closed -$323K – 2696
2022
Q1 		$323K Hold
40,741
– – ﹤0.01% 2577
2021
Q4 		$382K Hold
40,741
– – ﹤0.01% 2628
2021
Q3 		$644K Hold
40,741
– – ﹤0.01% 2390
2021
Q2 		$880K Sell
40,741
-167
-0.4% -$3.38K ﹤0.01% 2274
2021
Q1 		$829K Buy
40,908
+888
+2% +$17.5K ﹤0.01% 2171
2020
Q4 		$716K Sell
40,020
-6,282
-14% -$92.3K ﹤0.01% 2145
2020
Q3 		$538K Buy
46,302
+6,773
+17% +$78.7K ﹤0.01% 2110
2020
Q2 		$365K Sell
39,529
-1,127
-3% -$10.1K ﹤0.01% 2231
2020
Q1 		$423K Buy
40,656
+5,636
+16% +$71.8K ﹤0.01% 2035
2019
Q4 		$627K Sell
35,020
-4,540
-11% -$67.1K ﹤0.01% 2147
2019
Q3 		$494K Buy
39,560
+8,797
+29% +$145K ﹤0.01% 2305
2019
Q2 		$609K Buy
30,763
+10,847
+54% +$232K ﹤0.01% 2119
2019
Q1 		$419K Buy
+19,916
New +$364K ﹤0.01% 2175
2018
Q4 		– Sell
-15,782
Closed -$582K – 2774
2018
Q3 		$582K Buy
15,782
+2,900
+23% +$127K ﹤0.01% 2022
2018
Q2 		$647K Buy
12,882
+6,100
+90% +$269K ﹤0.01% 1986
2018
Q1 		$248K Buy
+6,782
New +$208K ﹤0.01% 2289

Other funds holding AXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

UBS AM's AXGN Position: Q2 2026 in Review

UBS AM increased its Axogen (AXGN) stake by 31% in Q2 2026, buying an estimated $756K and bringing the position to 79,524 shares worth $3.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1759.

UBS AM first reported a position in AXGN in Q1 2018 and has held it in 24 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • UBS AM held 79,524 shares of Axogen worth $3.67M as of Q2 2026.
  • UBS AM bought 18,754 Axogen shares in Q2 2026, an estimated $756K.
  • Axogen made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1759 holding.
  • UBS AM first reported a position in Axogen in Q1 2018 and has held it in 24 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.